Changing Perceptions About Hereditary Diseases in Africa Through Biotechnology

When science meets storytelling, change begins. This was the pulse of our recent Global Biotech Revolution webinar – a stirring, pan-African dialogue that brought together advocates, scientists, and students to confront the myths surrounding genetic and hereditary diseases. From Kenya to Uganda to South Africa, our speakers painted not only a scientific picture of genetics, but also a deeply human one – revealing how awareness, empathy, and biotechnology can turn stigma into strength.

Understanding Genetic Diseases

Adding a vital scientific lens to the discussion, Yvonne Zilpah- Ojijo, founder and lead cancer consultant at GeneTrans Limited, explored how hereditary diseases shape lives across Africa. She reminded participants that “Genetic diseases are far more common in Africa than most people assume,” noting that nearly 50 million Africans live with rare genetic conditions, with sickle cell disease as the most prevalent. Drawing on her background in molecular biology, Yvonne simplified the science of inheritance, from dominant and recessive genes to X-linked patterns, showing how a single mutation can define health outcomes. Using sickle cell anaemia as an example, she explained how one genetic change causes severe illness yet also provides resistance to malaria.

Her reflections carried both scientific depth and emotional weight. Recalling the loss of two friends, Wendy and Cindy, to sickle cell anaemia and acute leukaemia, she asked, “What if ignorance was replaced by science and fear was replaced by hope?” Through her DNA Diaries podcast, Yvonne continues to bridge science and society, turning knowledge into empowerment.

Replacing Blame with Biology

“Biotechnology is not just science,” said Christine Mutena, founder of Rare Disorders Kenya. “It’s a bridge to dignity, inclusion, and better futures for families.” Christine opened the session with a message that set the tone for the evening: Genetics is not destiny,

understanding is. Her presentation, Understanding Rare Disorders, underscored the urgent need to replace centuries of stigma with science. She reminded the audience that over 300 million people live with rare diseases globally, many of which are genetic. In Kenya and across Africa, stigma and misinformation compound the burden. “When we understand the biology,” she said, “we move the blame away from families. We replace guilt with knowledge and compassion with policy.”

Christine’s organization, Rare Disorders Kenya, advocates for awareness, research, and policy

frameworks that protect affected families. Her message was clear: the future of biotech in Africa must be both scientifically sound and socially inclusive.

The Voice of Lived Experience

If Christine spoke to the science, Innocent Clare Naku, founder of Sickle Cell Healthcare Uganda, gave it a heartbeat. Her testimony carried both advocacy and anguish, a rare honesty that silenced the virtual room. With conviction, she shared a story from her work in Ugandan communities: “We lost a four-year-old boy not to sickle cell disease, but to ignorance,” she said remorsefully. “His mother believed a demon from Lake Victoria was sucking his blood. By the time we went back to help, the child was gone.”

The tragedy was not an isolated event but a mirror of what happens when cultural beliefs,

misinformation, and limited access to healthcare intersect. Innocent explained that while Africa carries 66% of the global sickle cell burden, awareness remains dangerously low.

Her team’s “Know Your Genotype” campaign – offering free community testing and education – seeks to reverse this trend through grassroots biotech literacy. “We are targeting three zeros,” she said. “Zero new cases, Zero stigma, and Zero sickle-cell-related deaths.”

Her words were both a challenge and a call to action: “Over to you, biotechnologists,” she urged. “Bring us affordable treatments. Bring science closer to the people.”

Bridging Science and Humanity

From South Africa, Lisa Mbhele is a genetic counsellor registered with the HPCSA and currently the only genetic counsellor serving at two major public hospitals in Durban.

She built on these narratives from a healthcare perspective. She described her role as “a bridge between science and care”, helping families navigate the emotional terrain of genetic diagnoses.

Lisa outlined the genetic counsellor’s mission – simplifying complex science into empathy-driven communication. “Our goal is to move families from fear to acceptance,” she explained. “When parents understand the genetics of a condition, they realize it’s not their fault.”

She spoke about conditions such as sickle cell disease, albinism, and hereditary cancers, which often carry deep cultural and spiritual misconceptions. “Parents ask, ‘Is it my fault?’ or ‘Is God punishing me?’” she said. “Knowledge is power -and clarity brings healing.”

Lisa’s insights on cultural sensitivity struck a chord. She emphasized that genetic literacy in Africa is not just about labs and diagnostics – it’s about reshaping conversations. “Faith leaders, teachers, and clinicians must all speak the same language of truth and compassion,” she said.

A Pan-African Dialogue on Dignity

The session chat was alive with voices from across Africa, from Tanzania, Nigeria, Rwanda, Kenya to Uganda, and South Africa. “Knowledge is power!” one participant wrote. Another added, “Acceptance begins with awareness -and awareness starts with us.”

These reflections captured the very spirit of GBR’s mission: to empower young scientists to lead global change through biotechnology, ethics, and collaboration.

In the final moments, as participants exchanged gratitude and contacts, a sense of unity filled the room. The conversation had gone beyond genes – it had become about justice, empathy, and inclusion.

A Future Beyond Fear

As the discussion drew to a close, one truth stood out: biotechnology’s role in Africa cannot be confined to laboratories. It must extend to classrooms, religious institutions, clinics, and community halls. It must heal not just diseases, but the narratives that surround them.

“Together,” Christine had said, “we must integrate genetics, biotech, and healthcare into policy and systems.”

The evening ended with renewed purpose – that through innovation, advocacy, and empathy, Africa can redefine its genetic future. At GBR, we believe this is only the beginning. From stigma to science, from isolation to inclusion — the movement has begun.

By John Ricky, Felix Nyabeni, and Gugulethu Buthelezi